J.W. Cole Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

J.W. Cole Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.89M	Buy	24,605 +15,549	+172%	+$2.1M	0.07%	304
2026 Q1	$1.16M	Sell	9,056 -1,447	-14%	-$181K	0.04%	351
2025 Q4	$1.23M	Sell	10,503 -13,077	-55%	-$1.5M	0.03%	568
2025 Q3	$2.36M	Sell	23,580 -12,967	-35%	-$1.17M	0.05%	394
2025 Q2	$3.03M	Buy	36,547 +540	+1%	+$43.1K	0.06%	289
2025 Q1	$2.92M	Sell	36,007 -1,187	-3%	-$106K	0.09%	230
2024 Q4	$3.35M	Buy	37,194 +1,450	+4%	+$140K	0.14%	152
2024 Q3	$3.53M	Sell	35,744 -540	-1%	-$53.1K	0.15%	140
2024 Q2	$3.36M	Buy	36,284 +279	+0.8%	+$25K	0.16%	137
2024 Q1	$3.42M	Buy	36,005 +826	+2%	+$76.6K	0.17%	131
2023 Q4	$3.14M	Sell	35,179 -2,499	-7%	-$186K	0.18%	128
2023 Q3	$2.75M	Sell	37,678 -382	-1%	-$30.5K	0.2%	120
2023 Q2	$3.17M	Buy	38,060 +781	+2%	+$65.3K	0.23%	107
2023 Q1	$2.84M	Buy	37,279 +542	+1%	+$45K	0.2%	126
2022 Q4	$3.05M	Sell	36,737 -5,440	-13%	-$440K	0.23%	111
2022 Q3	$3.35M	Buy	42,177 +5,221	+14%	+$440K	0.28%	83
2022 Q2	$2.75M	Buy	36,956 +13,728	+59%	+$1.03M	0.22%	115
2022 Q1	$2.09M	Buy	23,228 +5,638	+32%	+$521K	0.14%	171
2021 Q4	$1.97M	Sell	17,590 -279,568	-94%	-$33.7M	0.13%	183
2021 Q3	$22.5M	Buy	297,158 +285,035	+2,351%	+$36.7M	1.61%	10
2021 Q2	$1.64M	Sell	12,123 -314	-3%	-$41.3K	0.13%	185
2021 Q1	$1.69M	Sell	12,437 -601	-5%	-$90K	0.16%	154
2020 Q4	$1.83M	Buy	13,038 +8,089	+163%	+$1.04M	0.19%	128
2020 Q3	$551K	Sell	4,949 -8,797	-64%	-$986K	0.04%	399
2020 Q2	$1.54M	Buy	+13,746	New	+$1.35M	0.23%	120
2020 Q1	–	Sell	-6,456	Closed	-$614K	–	518
2019 Q4	$614K	Buy	+6,456	New	+$558K	0.08%	266

Other funds holding XBI

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

PSP Research Newtown Square, Pennsylvania $188M AUM

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

NHFG

New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

MFS

Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return

LRPA

L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

J.W. Cole Advisors's XBI Position: Q2 2026 in Review

J.W. Cole Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 172% in Q2 2026, buying an estimated $2.1M and bringing the position to 24,605 shares worth $3.89M. The position accounts for 0.07% of the portfolio, ranked #304.

J.W. Cole Advisors first reported a position in XBI in Q4 2019 and has held it in 26 quarters since. The position peaked at $22.5M in Q3 2021. 260 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

J.W. Cole Advisors held 24,605 shares of State Street SPDR S&P Biotech ETF worth $3.89M as of Q2 2026.
J.W. Cole Advisors bought 15,549 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $2.1M.
State Street SPDR S&P Biotech ETF made up 0.07% of J.W. Cole Advisors's portfolio in Q2 2026, its #304 holding.
J.W. Cole Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 26 quarters since.
J.W. Cole Advisors's State Street SPDR S&P Biotech ETF position peaked at $22.5M in Q3 2021.
260 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.